Bowhead Specialty
Bowhead Specialty's revenue rose 29.6% to $552 million in fiscal 2025. Its net margin was 9.8%, up from 9.0% a year earlier. Free cash flow was $326 million, up 12.0%. The diluted share count rose 13.7%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Bowhead Specialty does
Bowhead Specialty is a property and casualty insurer that sells commercial specialty insurance, mainly casualty, professional liability and healthcare liability coverage, to policyholders of varied size, industry and complexity. It was founded in September 2020 and says it is backed by a private equity fund managed by Gallatin Point Capital and by its strategic partner, American Family Insurance (AmFam).
It uses two underwriting models. The craft model uses experienced underwriters for large, complex and higher-severity risks. The digital model, which includes Baleen Specialty and its express offerings, uses standardized products and technology for smaller, simpler risks. Its policies are mostly written on a non-admitted, or excess and surplus lines, basis, which is free of rate and policy form restrictions.
It sells through a select group of insurance brokers, and its revenue comes from premiums it writes plus investment income. It buys reinsurance from other insurers to pass on part of its risk.
Its biggest risks, as it describes them
- Misjudging the risks it underwrites, or reserves that prove too low for actual losses.
- Losing its strategic relationship with AmFam, or a drop in AmFam's financial strength rating.
- Relying on a select group of brokers for most of its business.
- Being unable to buy reinsurance on acceptable terms, and the credit risk of its reinsurers.
- Intense competition in the specialty insurance market.
Income statement
From fiscal 2022 to 2025, earnings per share grew 50.1% a year and net income 68.2% a year, as new shares raised the share count by 40% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | 65 | 127 | 108 | 194 |
| Debt incl. finance leases | — | — | 0 | 146 |
| Net debt (negative means net cash) | — | — | −108 | −47 |
| Net debt to EBITDA | — | — | −1.9x | −0.7x |
| Debt to equity | — | — | 0.0x | 0.3x |
| Interest coverage | — | — | 70.7x | 34.5x |
| Current ratio | — | — | — | — |
| Quick ratio | — | — | — | — |
Cash flow
Projections
Project Bowhead Specialty's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
No officer, director or 10% owner of Bowhead Specialty reported buying or selling its shares on the open market between November 20, 2025 and November 19, 2026.
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 133.1% | 118.6% | 88.7% |
| Altman Z'' | — | — | — |
| Accruals ratio | — | −19.1% | −13.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | — | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | — | — | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | — | — | Fail |
| Current ratio rose | — | — | — |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | — | — | Fail |
| F-score | — | — | — |
Compare
Put Bowhead Specialty side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Bowhead Specialty | FY25 | 29.6% | — | 59.1% | 16.7% | −0.7x | — | |
| Porch Group | FY25 | 10.2% | 7.6% | 13.7% | 8.0% | 5.5x | 6 | Compare |
| Hippo | FY25 | 25.9% | — | 1.9% | — | — | — | Compare |
| Global Indemnity Group, LLC | FY25 | 2.0% | — | — | 3.9% | −1.7x | — | Compare |
| James River Group | FY25 | −2.8% | — | −3.4% | — | — | — | Compare |
4 years of figures
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 188 | 283 | 426 | 552 |
| Revenue growth | — | 51.1% | 50.2% | 29.6% |
| Gross profit | — | — | — | — |
| Research and development | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | 11 | 25 | 38 | 54 |
| Diluted EPS (US$) | 0.47 | 1.04 | 1.29 | 1.59 |
| Diluted shares (millions) | 24 | 24 | 30 | 34 |
| Cash flow | ||||
| Cash from operations | 182 | 236 | 294 | 332 |
| Capital expenditure | 4 | 4 | 3 | 6 |
| Free cash flow | 178 | 232 | 291 | 326 |
| Dividends paid | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 1 | 4 | 7 |
| Balance sheet at fiscal year end | ||||
| Cash and short-term investments | 65 | 127 | 108 | 194 |
| Debt incl. finance leases | — | — | 0 | 146 |
| Total assets | — | 1,028 | 1,654 | 2,371 |
| Total liabilities | — | 836 | 1,284 | 1,922 |
| Shareholders' equity | — | 192 | 370 | 448 |
| Margins and ratios | ||||
| Gross margin | — | — | — | — |
| Operating margin | — | — | — | — |
| Net margin | 6.0% | 8.8% | 9.0% | 9.8% |
| Free cash flow margin | 94.7% | 82.0% | 68.4% | 59.1% |
| Rule of 40 (growth + FCF margin) | — | 133.1% | 118.6% | 88.7% |
| Return on capital | — | — | — | 16.7% |
| Return on equity | — | — | 13.6% | 13.1% |
| Return on assets | — | — | 2.9% | 2.7% |
| Net debt to EBITDA | — | — | −1.9x | −0.7x |